Search Results - "Koup, R.A"
-
1
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
Published in Vaccine (16-12-2010)“…Abstract Ebola virus causes irregular outbreaks of severe hemorrhagic fever in equatorial Africa. Case mortality remains high; there is no effective treatment…”
Get full text
Journal Article -
2
Sustained HIV release by single persisting CD4+ T cells during latency disruption
Published in Journal of Virus Eradication (01-12-2015)Get full text
Journal Article -
3
Combination therapy with the broadly neutralizing antibody VRC07-523LS and the latency reversal agent Vorinostat fails to substantially reduce latent, resting CD4+ T cell infection or reduce low-level viremia
Published in Journal of the International AIDS Society (01-07-2021)Get full text
Journal Article -
4
Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis
Published in The Lancet regional health. Europe (01-12-2022)“…Indicator-condition (IC) guided HIV testing is a feasible and cost-effective strategy to identify undiagnosed people living with HIV (PLHIV), but remains…”
Get full text
Journal Article -
5
VRC 004: Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine in Healthy Uninfected Adults (VRC-HIVDNA009-00-VP)
Published in Journal of allergy and clinical immunology (01-04-2005)Get full text
Journal Article -
6
Why high levels of virus-specific CTL persist in HIV1-infected individuals
Published in Research in immunology (Paris) (01-01-1989)Get more information
Journal Article